NGS technologies as a turning point in rare disease research, diagnosis and treatment

A Fernandez-Marmiesse, S Gouveia… - Current medicinal …, 2018 - ingentaconnect.com
Approximately 25-50 million Americans, 30 million Europeans, and 8% of the Australian
population have a rare disease. Rare diseases are thus a common problem for clinicians …

[HTML][HTML] The many faces of the zinc finger protein 335 in brain development and immune system

D Li, Z Quan, J Ni, H Li, H Qing - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Abstract Zinc finger protein 335 (ZNF335) plays a crucial role in the methylation and,
consequently, regulates the expression of a specific set of genes. Variants of the ZNF335 …

“Ears of the lynx” MRI sign is associated with SPG11 and SPG15 hereditary spastic paraplegia

B Pascual, ST De Bot, MR Daniels… - American Journal …, 2019 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The “ears of the lynx” MR imaging sign has been
described in case reports of hereditary spastic paraplegia with a thin corpus callosum …

Loss of PYCR2 causes neurodegeneration by increasing cerebral glycine levels via SHMT2

N Escande-Beillard, A Loh, SN Saleem, K Kanata… - Neuron, 2020 - cell.com
Patients lacking PYCR2, a mitochondrial enzyme that synthesizes proline, display postnatal
degenerative microcephaly with hypomyelination. Here we report the crystal structure of the …

Molecular Pathogenic Mechanisms of Hypomyelinating Leukodystrophies (HLDs)

T Torii, J Yamauchi - Neurology International, 2023 - mdpi.com
Hypomyelinating leukodystrophies (HLDs) represent a group of congenital rare diseases for
which the responsible genes have been identified in recent studies. In this review, we briefly …

Disease variants of human Δ1-pyrroline-5-carboxylate reductase 2 (PYCR2)

SM Patel, J Seravalli, X Liang, JJ Tanner… - Archives of biochemistry …, 2021 - Elsevier
Abstract Pyrroline-5-carboxylate reductase (PYCR in humans) catalyzes the final step of l-
proline biosynthesis by catalyzing the reduction of L-Δ 1-pyrroline-5-carboxylate (L-P5C) to l …

Genetic analysis of Pycr1 and Pycr2 in mice

MG Stum, ALD Tadenev, KL Seburn, KE Miers… - Genetics, 2021 - academic.oup.com
The final step in proline biosynthesis is catalyzed by three pyrroline-5-carboxylate
reductases, PYCR1, PYCR2, and PYCR3, which convert pyrroline-5-carboxylate (P5C) to …

Hypomyelinating leukodystrophy 10 (HLD10)-associated mutations of PYCR2 form large size mitochondria, inhibiting oligodendroglial cell morphological …

T Torii, R Shirai, R Kiminami, S Nishino, T Sato… - Neurology …, 2022 - mdpi.com
Hypomyelinating leukodystrophy 10 (HLD10) is an autosomal recessive disease related to
myelin sheaths in the central nervous system (CNS). In the CNS, myelin sheaths are derived …

Differential degradation of TRA2A and PYCR2 mediated by ubiquitin E3 Ligase E4B

Y Lu, B Jiang, K Peng, S Li, X Liu, B Wang… - Frontiers in Cell and …, 2022 - frontiersin.org
E4B belongs to the U-box E3 ligase family and functions as either an E3 or an E4 enzyme in
protein ubiquitination. Transformer2A (TRA2A) and Pyrroline-5-carboxylate reductase 2 …

Expanding the genotypic spectrum of PYCR2 and a common ancestry in Thai patients with hypomyelinating leukodystrophy 10

C Manaspon, P Boonsimma, C Phokaew… - American Journal of …, 2021 - Wiley Online Library
PYCR2 pathogenic variants lead to an autosomal recessive hypomyelinating
leukodystrophy 10 (HLD10), characterized by global developmental delay, microcephaly …